Alaina Vidmar, MD
Alaina Vidmar, MD, is an Associate Professor in Pediatric Endocrinology, a Board-Certified Pediatric Obesity Medicine Specialist, and the Medical Director of the Obesity Medicine and Bariatric Surgery Program at Children’s Hospital Los Angeles. Dr. Vidmar received her medical degree and completed her residency in Pediatrics at the Children's Hospital of Wisconsin. She completed her fellowship in Pediatric Endocrinology at Children's Hospital Los Angeles. Dr. Vidmar’s lab is interested in four components of the treatment of obesity in youth:
- Chrononutrition: Dr. Vidmar is interested in investigating how pediatric chronobiological intersects with nutrition and obesity. She is gathering data to investigate how time-restricted eating effects cardiometabolic health and glycemic profiles in youth across the spectrum of beta-cell dysfunction.
- Intersection between obesity pharmacotherapy and eating phenotyping: Dr. Vidmar's lab aims to better understand how obesity pharmacotherapy treats and moderates the relationship between eating phenotypes and other clinical outcomes.
- Wearable technology: Dr. Vidmar’s lab aims to utilize continuous glucose monitors as real-time biofeedback to augment engagement with lifestyle modification, obesity pharmacotherapy, and surgical interventions for obesity management in youth.
- Integration of obesity pharmacotherapy and pre-and postoperative bariatric surgery algorithms: Dr. Vidmar’s lab is examining how to apply obesity pharmacotherapy algorithms safely and effectively to pediatric bariatric surgery pathways to augment clinical and psychosocial outcomes in the immediately and long term follow up periods.
Pediatric Obesity
Type 2 Diabetes
Pediatric Metabolic and Bariatric Surgery
Prader Willi Syndrome
Education
Medical College of Wisconsin
Children's Hospital of Wisconsin, Pediatric Internship
Children's Hospital of Wisconsin, Pediatric Residency
Children's Hospital of Los Angeles, Pediatric Endocrinology Fellowship
Accomplishments
American Board of Pediatrics
American Board of Pediatric Endocrinology
American Board of Obesity Medicine
The Obesity Society
Prader-Willi Association
Foundation for Prader-Willi Research
Pediatric Endocrine Society
The Endocrine Society
The American Diabetes Association
American Society for Metabolic and Bariatric Surgery
Publications
Vidmar AP, Wee CP, Salvy SJ, Abduljalil Bakhsh J*, Goran MI. Timing of meal consumption on glucose profiles in Latino adolescents with obesity. Hormone Research in Pediatrics. 2024; in press.
Dhillon A*, Mayer M*, Kysh L, Fox D S, Hegedus E*, Vidmar AP. Cost-Effectiveness Analysis of Individual-Level Pediatric Obesity Interventions: A Scoping Review. Pediatr Obes. 2024 Mar;19(3):e13100. doi: 10.1111/ijpo.13100. Epub 2024 Jan 29. PMID: 38287524.
Hegedus E*, Vu MH, Salvy SJ, Bakhsh J*, Goran MI, Raymond JK, Espinoza JC, Vidmar AP. Randomized Controlled Feasibility Trial of Late 8-Hour Time-Restricted Eating for Adolescents With Type 2 Diabetes. Journal of the Academy of Nutrition and Dietetics. October 28, 2023; DOI:https://doi.org/10.1016/j.jand.2023.10.012.
Naguib MN, Hegedus E, Raymond JK, Goran MI, Salvy SJ, Wee CP, Durazo-Arvizu R, Moss L, Vidmar AP. Continuous Glucose Monitoring in Adolescents With Obesity: Monitoring of Glucose Profiles, Glycemic Excursions, and Adherence to Time Restricted Eating Programs. Front Endocrinol (Lausanne). 2022;13:841838.
Vidmar AP, Yamashita N, Fox DS, Hegedus E, Wee CP, Salvy SJ. Can a Behavioral Weight-Loss Intervention Change Adolescents' Food Addiction Severity? Child Obes. 2022 Jan 7.
Vidmar AP, Naguib M, Raymond JK, Salvy SJ, Hegedus E, Wee CP, Goran MI. Time-Limited Eating and Continuous Glucose Monitoring in Adolescents with Obesity: A Pilot Study. Nutrients. 2021 Oct 21;13(11).
Vidmar AP, Jones RB, Wee CP, Berger PK, Plows JF, Claudia Rios RD, Raymond JK, Goran MI. Timing of food consumption in Hispanic adolescents with obesity. Pediatr Obes. 2021 Jul;16(7):e12764.
Vidmar AP, Pretlow R, Borzutzky C, Wee CP, Fox DS, Fink C, Mittelman SD. An addiction model-based mobile health weight loss intervention in adolescents with obesity. Pediatr Obes. 2019 Feb;14(2):e12464.
Research
Pediatric Obesity
Obesity Pharmacotherapies
Pediatric Metabolic and Bariatric Surgery
Time Restricted Eating
Research Studies
To test the effectiveness of an addiction-based weight loss intervention, embodied first as a smartphone app with telephone coaching (AppCoach) compared to (1) addiction model based weight-loss app alone (App) and (2) multi-disciplinary in-clinic weight loss intervention (Clinic) on weight outcomes of overweight and obese adolescents at 3, 6, 12 and 18 months post enrollment.
This research is being done to test the safety and effectiveness of intranasal carbetocin to treat Prader Willi Syndrome.
To find out if Time-Limited Eating can help teens lose weight.
Media
The Guardian - Ditch mouthwash, always floss: experts on their wellbeing dos and don’ts
Associated Press - Weight-loss drug Saxenda effective for kids as young as 6, study shows
Cafe Mom - 5 Things Parents Considering Weight Loss Drugs for Their Kids Need To Know
Knowable Magazine - Understanding the sudden rise of type 2 diabetes in children
Elsevier - When You Eat May Impact Your Overall Health, Nutrition Experts Say
Medscape - Kids and Anti-Obesity Medications: Real-World Challenges
BBC - Will a glucose monitor help you be healthier?
WebMD - Is Childhood Obesity a National Public Health Emergency?
NBC News - What to know about weight loss drugs for teens
YouTube: ResearCHLA Media Day 2023
Future-Proofing Children's Health: Reducing the Impact of Obesity and Diabetes